Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
GlaxoSmithKline (GSK)
Share Price: 1,494.00p Change Today: 24.40p  Market Cap: 74,120m

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 30,528.95 7,842.43 113.65p 12.9 7.8 +2% 79.97p 5.6%
31-Dec-19 31,281.08 7,720.23 114.70p 12.8 13.9 +1% 80.08p 5.6%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 04-Dec-2018 10:07 RNS
Total Voting Rights 03-Dec-2018 14:00 RNS
GSK reaches agreement to acquire TESARO 03-Dec-2018 12:02 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
03-Dec-18 Exercise of option David Redfern 1,013.00p 888 8,995.44
09-Nov-18 Transfer From Victoria Whyte 0.000p 8 0.00
09-Nov-18 Buy Victoria Whyte 1,561.10p 8 124.89

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency UK Pounds
Share Price 1,494.00p
Change Today 24.40p
% Change 1.66 %
Volume 3,994,081
10-Dec-18 Close 1,469.60p
Shares Issued 4,961.20m
Market Cap 74,120m
Year End 31-Dec-17

What The Brokers Say

Strong Buy 9
Buy 2
Neutral 14
Sell 0
Strong Sell 2
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q3 Q2
Ex-Div 15-Nov-18 09-Aug-18
Paid 10-Jan-19 11-Oct-18
Amount 19.00p 19.00p

Trades for 11-Dec-2018

Time Volume / Share Price
14:36 154 @ 1,494.00p
14:36 66 @ 1,494.00p
14:36 434 @ 1,494.00p
14:36 158 @ 1,494.00p
14:36 400 @ 1,494.20p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley



www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/ www.digitallook.com